BRIEF published on 05/13/2025 at 07:05, 10 months 5 days ago Innate Pharma Reports First Quarter 2025 Results Financial Results Clinical Trials Innate Pharma Sanofi Investment Lacutamab FDA
PRESS RELEASE published on 05/13/2025 at 07:00, 10 months 5 days ago Inside Information / News release on accounts, results Innate Pharma reports Q1 2025 business update with €15 million investment by Sanofi, FDA Breakthrough Therapy Designation for lacutamab, and cash position of €72.5 million FDA Financial Results Sanofi Innate Pharma Q1 2025
BRIEF published on 05/02/2025 at 15:27, 10 months 16 days ago Sanofi increases its stake in Innate Pharma Capital Actions Crossing Thresholds Sanofi Innate Pharma
BRIEF published on 04/29/2025 at 21:05, 10 months 19 days ago Innate Pharma Presents Promising Preclinical Data for IPH4502 at AACR 2025 Preclinical Data Innate Pharma IPH4502 Nectin-4 Antibody Drug Conjugate
PRESS RELEASE published on 04/29/2025 at 21:00, 10 months 19 days ago Inside Information / Other news releases Innate Pharma presents preclinical data for IPH4502, a Nectin-4 targeting ADC, showing superior anti-tumor efficacy in multiple cancer models at AACR 2025 Annual Meeting Preclinical Data Innate Pharma IPH4502 AACR 2025 Nectin-4 ADC
BRIEF published on 04/24/2025 at 07:40, 10 months 24 days ago Innate Pharma Secures €15M Sanofi Investment Capital Increase Innate Pharma Sanofi Investment BCMA ANKET Biotech Partnership
PRESS RELEASE published on 04/24/2025 at 07:35, 10 months 24 days ago Inside Information / Other news releases Innate Pharma announces €15M investment by Sanofi to strengthen collaboration and support pipeline execution. Closing of the capital increase expected on April 25, 2025 Investment Collaboration Sanofi Innate Pharma Pipeline Execution
BRIEF published on 04/23/2025 at 07:05, 10 months 25 days ago Innate Pharma Takes Back Rights and Sanofi Considers Investment Strategic Investment Sanofi Innate Pharma Acute Myeloid Leukemia CD123
PRESS RELEASE published on 04/23/2025 at 07:00, 10 months 25 days ago Inside Information / Other news releases Innate Pharma regains rights on CD123 targeting ANKET® as Sanofi plans strategic investment. SAR'579 (IPH6101) ongoing study shows promise in AML patients Strategic Investment Sanofi Innate Pharma CD123 Targeting SAR'579
BRIEF published on 04/16/2025 at 07:05, 11 months 2 days ago Innate Pharma General Meeting Announced for May 22, 2025 Shareholders Biotechnology General Meeting Innate Pharma Marseille
Published on 03/18/2026 at 21:00, 44 minutes ago PLDT's Smart Selects Amdocs to Transform Retail Operations with AI-Powered Store Genie
Published on 03/18/2026 at 19:05, 2 hours 39 minutes ago Deposit Modeling at Thor Shows that the Proven Thor Epithermal Deposit is Flanked on Both Sides by a Much Larger Deposit
Published on 03/18/2026 at 18:10, 3 hours 34 minutes ago Silver X Mining Closes C$69M Brokered Private Placement of Secured Convertible Debentures
Published on 03/18/2026 at 14:30, 7 hours 14 minutes ago Ground Geophysics Underway at Murphy Lake, 5 km From Isoenergy's Hurricane Deposit, Athabasca Basin
Published on 03/18/2026 at 14:15, 7 hours 29 minutes ago Apex Provides Phase I Drilling Update at the Rift Rare Earth Project in Nebraska, U.S.A.
Published on 03/18/2026 at 18:53, 2 hours 51 minutes ago EQS-Adhoc: Formycon AG postpones the publication of its audited annual and consolidated financial statements for 2025
Published on 03/18/2026 at 18:37, 3 hours 7 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 03/18/2026 at 18:15, 3 hours 29 minutes ago Northern Data Group releases audited FY 2025 Financial Results
Published on 03/18/2026 at 17:43, 4 hours 1 minute ago Voluntary public takeover bid by B&C Holding Österreich GmbH for Semperit Aktiengesellschaft Holding
Published on 03/18/2026 at 19:41, 2 hours 3 minutes ago Covivio - Conditions of availability of the 2025 Universal Registration Document
Published on 03/18/2026 at 18:00, 3 hours 44 minutes ago Deezer achieves profitability in FY25 as strategy delivers tangible results
Published on 03/18/2026 at 17:45, 3 hours 59 minutes ago Infotel : 2025 full-year results. Launch of a new Infotel 2030 strategic plan. Revenue target of €500 million by 2030.
